Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADVM
4676
PUT
DELISTED
Adverum Biotechnologies
ADVM
| $297K | ﹤0.01% |
+2,500
| New | +$207K |
|
|
OLP
4677
One Liberty Properties
OLP
$525M
| $297K | ﹤0.01% |
10,266
+3,449
| +51% | +$99.6K |
|
4678
York Water
YORW
$513M
| $297K | ﹤0.01% |
8,326
+4,281
| +106% | +$147K |
|
4679
Byline Bancorp
BY
$1.78B
| $296K | ﹤0.01% |
15,502
+9,748
| +169% | +$187K |
|
|
DHIL
4680
DELISTED
Diamond Hill
DHIL
| $296K | ﹤0.01% |
2,092
+876
| +72% | +$125K |
|
4681
Merchants Bancorp
MBIN
$2.47B
| $296K | ﹤0.01% |
26,057
+18,749
| +257% | +$257K |
|
|
JCAP
4682
DELISTED
Jernigan Capital, Inc.
JCAP
| $296K | ﹤0.01% |
14,466
+5,161
| +55% | +$109K |
|
4683
PUT
iShares MSCI ACWI ETF
ACWI
$33.3B
| $295K | ﹤0.01% |
4,000
-57,600
| -94% | -$4.2M |
|
4684
CALL
Quest Diagnostics
DGX
$26.2B
| $295K | ﹤0.01% |
2,900
-4,000
| -58% | -$384K |
|
4685
PUT
Zoetis
ZTS
$32.4B
| $295K | ﹤0.01% |
2,600
-1,031,400
| -100% | -$108M |
|
4686
Black Stone Minerals
BSM
$2.99B
| $294K | ﹤0.01% |
18,996
+400
| +2% | +$6.82K |
|
4687
Collegium Pharmaceutical
COLL
$972M
| $293K | ﹤0.01% |
22,300
-29,557
| -57% | -$395K |
|
4688
CALL
Resideo Technologies
REZI
$3.98B
| $293K | ﹤0.01% |
13,372
-496
| -4% | -$10.5K |
|
4689
PUT
Zillow
ZG
$7.29B
| $293K | ﹤0.01% |
6,400
+1,800
| +39% | +$70.7K |
|
|
TUP
4690
PUT
DELISTED
Tupperware Brands Corporation
TUP
| $293K | ﹤0.01% |
15,400
+3,700
| +32% | +$83.1K |
|
4691
CALL
Church & Dwight Co
CHD
$24.3B
| $292K | ﹤0.01% |
4,000
-20,200
| -83% | -$1.5M |
|
|
IIF
4692
Morgan Stanley India Investment Fund
IIF
$220M
| $292K | ﹤0.01% |
13,922
| – | – |
|
4693
Transmedics
TMDX
$2.71B
| $292K | ﹤0.01% |
+10,088
| New | +$275K |
|
4694
Live Oak Bancshares
LOB
$1.97B
| $291K | ﹤0.01% |
16,946
-3,991
| -19% | -$65.6K |
|
4695
CALL
Paylocity
PCTY
$8.28B
| $291K | ﹤0.01% |
3,100
+500
| +19% | +$47.5K |
|
|
SGEN
4696
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $291K | ﹤0.01% |
4,200
+600
| +17% | +$42K |
|
|
ACRE
4697
Ares Commercial Real Estate
ACRE
$268M
| $290K | ﹤0.01% |
19,530
+10,132
| +108% | +$153K |
|
4698
Ocular Therapeutix
OCUL
$1.92B
| $290K | ﹤0.01% |
65,763
+42,885
| +187% | +$159K |
|
|
VRTV
4699
DELISTED
VERITIV CORPORATION
VRTV
| $290K | ﹤0.01% |
14,977
+5,566
| +59% | +$128K |
|
4700
Verastem
VSTM
$511M
| $289K | ﹤0.01% |
15,984
+10,960
| +218% | +$248K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.